This year marks an exceptional milestone as we celebrate two decades of improving lives through genetic testing! Over the past twenty years, our journey has been one of significant progress and innovation.
The need for genetic testing can fluctuate during pregnancy, which is why PreventionGenetics offers multiple testing options and has genetics specialists available to help guide you through your patients’ genetic testing journey to work towards the best possible care for your patients.
An exciting new name for some old favorites.
In an effort to make genetic testing more accessible, we’re now offering a Patient Prompt Pay (self-pay) discount of 10% if payment is received in full when we receive the test requisition form (TRF).
PreventionGenetics, a subsidiary of Exact Sciences Corp., announced today that it was recently granted marketing authorization for the POMC/PCSK1/LEPR companion diagnostic (CDx) genetic test as a Class II device by the Center for Devices and Radiological Health (CDRH), a division of the Food and Drug Administration (FDA). Developed in collaboration with Rhythm Pharmaceuticals, Inc., the test is the first FDA-authorized Class II molecular companion diagnostic device.
